World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
134
Citations
83870
World Ranking
198
National Ranking
129

Molecular Biology

D-Index
126
Citations
75200
World Ranking
211
National Ranking
128

Overview

Peter D. Kwong is affiliated with Columbia University in the United States. Their research focuses primarily on medicine, immunology and microbiology, and biochemistry, genetics and molecular biology.

The main subfields of study in which they are active include infectious diseases, molecular biology, virology, immunology, and epidemiology. Their work covers topics such as SARS-CoV-2 and COVID-19 research, HIV research and treatment, monoclonal and polyclonal antibodies research, viral gastroenteritis research and epidemiology, animal virus infections, vaccines and immunoinformatics approaches, and glycosylation and glycoproteins research.

Frequent co-authors in their publications are:

  • Tongqing Zhou
  • John R. Mascola
  • Baoshan Zhang
  • Adam S. Olia
  • I-Ting Teng

The scientist publishes regularly in several venues. The most frequent publication venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cell Reports
  • Nature Communications
  • Science Translational Medicine
  • Vaccines

Representative recent papers include:

  • Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike, 2020, Nature
  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates, 2020, New England Journal of Medicine
  • Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization, 2021, Cell Host & Microbe
  • Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite, 2021, Cell Host & Microbe
  • LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants, 2022, Cell Reports

Best Publications

  • Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

    Peter D. Kwong;Richard Wyatt;James Robinson;Raymond W. Sweet

  • Antibody neutralization and escape by HIV-1

    Xiping Wei;Julie M. Decker;Shuyi Wang;Huxiong Hui

  • Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.

    Pengfei Wang;Manoj S. Nair;Lihong Liu;Sho Iketani;Sho Iketani

  • Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

    Xueling Wu;Zhi Yong Yang;Yuxing Li;Carl Magnus Hogerkorp

  • The antigenic structure of the HIV gp120 envelope glycoprotein

    Richard Wyatt;Peter D. Kwong;Elizabeth Desjardins;Raymond W. Sweet

  • Structural basis of cell-cell adhesion by cadherins.

    Lawrence Shapiro;Allison M. Fannon;Peter D. Kwong;Andrew Thompson

  • Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.

    Lihong Liu;Pengfei Wang;Manoj S. Nair;Jian Yu

  • Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01.

    Tongqing Zhou;Ivelin Georgiev;Xueling Wu;Zhi Yong Yang

  • A Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding

    Carlo D. Rizzuto;Richard Wyatt;Richard Wyatt;Nivia Hernández-Ramos;Nivia Hernández-Ramos;Ying Sun;Ying Sun

  • Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

    Hua-Xin Liao;Rebecca Lynch;Tongqing Zhou;Feng Gao;Feng Gao

  • HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

    Peter D. Kwong;Peter D. Kwong;Michael L. Doyle;Michael L. Doyle;David J. Casper;Claudia Cicala

  • Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

    Jason S. McLellan;Man Chen;M. Gordon Joyce;Mallika Sastry

  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.

    Kizzmekia S Corbett;Barbara Flynn;Kathryn E Foulds;Joseph R Francica

  • HIV vaccine design and the neutralizing antibody problem

    Dennis R Burton;Ronald C Desrosiers;Robert W Doms;Wayne C Koff

  • Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

    Jason S. McLellan;Marie Pancera;Chris Carrico;Jason Gorman

  • Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

    Jinghe Huang;Gilad Ofek;Leo Laub;Mark K. Louder

  • Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing

    John R. Mascola;Gary Nabel;Barton F. Haynes;Xueling Wu

  • Structural definition of a conserved neutralization epitope on HIV-1 gp120.

    Tongqing Zhou;Ling Xu;Barna Dey;Ann J. Hessell

  • Structure of a V3-Containing HIV-1 gp120 Core

    Chih-chin Huang;Min Tang;Mei-Yun Zhang;Shahzad Majeed

  • Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

    Jason S. McLellan;Man Chen;Sherman Leung;Kevin W. Graepel

  • Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization

    Pengfei Wang;Manoj S Nair;Lihong Liu;Sho Iketani;Sho Iketani

Frequent Co-Authors

John R. Mascola
John R. Mascola ModeX Therapeutics
Tongqing Zhou
Tongqing Zhou National Institutes of Health
Baoshan Zhang
Baoshan Zhang National Institute of Allergy and Infectious Diseases
Gwo-Yu Chuang
Gwo-Yu Chuang Moderna Therapeutics (United States)
Ivelin S. Georgiev
Ivelin S. Georgiev Vanderbilt University Medical Center
Lawrence Shapiro
Lawrence Shapiro Columbia University
Yongping Yang
Yongping Yang National Institutes of Health
Richard T. Wyatt
Richard T. Wyatt Scripps Research Institute
Marie Pancera
Marie Pancera Fred Hutchinson Cancer Research Center
Joseph Sodroski
Joseph Sodroski Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise in Immunology, pursuing advanced nursing roles can be a strategic career move. Programs such as acnp programs offer specialized training for those aiming to work in acute care settings, combining immunological knowledge with practical patient care skills.

Accelerated nursing pathways provide efficient routes to certification for those looking to enter the healthcare field rapidly. The nurse practitioner accelerated program options are ideal for students with prior degrees who want to fast-track their entry into advanced nursing roles that often involve immunology-related specialties.

For individuals without a nursing background, the availability of online adn programs for non nurses opens doors to foundational nursing education, setting the stage for future specialization in fields such as immunology or infectious disease.

Additionally, accelerated nursing programs are designed to help students efficiently transition into nursing careers, which can lead to diverse opportunities in immunology-related research and clinical practice. Exploring these pathways can significantly enhance one’s ability to contribute to immune health and disease management.

Best Scientists Citing Peter D. Kwong

Trending Scientists